FX.co ★ Sun Pharma's Leqselvi 8 Mg Tab Gets FDA Approval For Adults With Severe Alopecia Areata

Sun Pharmaceutical Industries Ltd. (SUNPHARMA, 524715) announced on Friday that the U.S. Food and Drug Administration has granted approval for Leqselvi 8 mg tablets. This medication is indicated for the treatment of adults with severe alopecia areata, a prevalent autoimmune disorder.

The approval was supported by the results of Phase 3 clinical trials, THRIVE-AA1 and THRIVE-AA2, which included alopecia areata patients experiencing at least a 50 percent loss of scalp hair.

By the end of the 24-week trials, over 30 percent of the participants achieved 80 percent or more scalp hair coverage. Additionally, up to 25 percent of the patients had nearly fully restored scalp hair.